Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-737 Cr₹-769 Cr₹-561 Cr₹-1,543 Cr₹-524 Cr

What is the latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-737 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-737 Cr
Mar2025₹-769 Cr
Mar2024₹-561 Cr
Mar2023₹-1,543 Cr
Mar2022₹-524 Cr

How is Cash Flow from Financing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-737 Cr
Negative
Mar2025 ₹-769 Cr
Negative
Mar2024 ₹-561 Cr
Negative
Mar2023 ₹-1,543 Cr
Negative
Mar2022 ₹-524 Cr -

Compare Cash Flow from Financing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹44,980.8 Cr 5.2% 4.8% 5.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,707.0 Cr 1.4% 6.7% 12% Stock Analytics
DIVIS LABORATORIES ₹303,962.0 Cr 11.1% 23.5% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,494.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹115,769.0 Cr 1.1% 11.8% 14.2% Stock Analytics
CIPLA ₹113,912.0 Cr 0.1% 6% -5.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

5.2%

4.8%

5.2%

SENSEX

3.3%

13.9%

-1.7%


You may also like the below Video Courses